Moneycontrol PRO

business

Sun's Halol audit may be a routine exercise: Expert

The US drug regulator is conducting audits at Sun Pharma's Halol facility in Gujarat. Sun had recalled multiple products made in this facility. Could this spell further trouble for Sun Pharma? Pharma Asia News India bureau chief Vikas Dandekar spoke with CNBC-TV18‘s Senthil Chengalvarayan and Sonia Shenoy to discuss the development.

LATEST VIDEOS

Watch More →

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Sections
ISO 27001 - BSI Assurance Mark